JPWO2022037528A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022037528A5
JPWO2022037528A5 JP2023510435A JP2023510435A JPWO2022037528A5 JP WO2022037528 A5 JPWO2022037528 A5 JP WO2022037528A5 JP 2023510435 A JP2023510435 A JP 2023510435A JP 2023510435 A JP2023510435 A JP 2023510435A JP WO2022037528 A5 JPWO2022037528 A5 JP WO2022037528A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
variable domain
single variable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023510435A
Other languages
English (en)
Japanese (ja)
Other versions
JP7821161B2 (ja
JP2023539453A (ja
JP2023539453A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/112758 external-priority patent/WO2022037528A1/zh
Publication of JP2023539453A publication Critical patent/JP2023539453A/ja
Publication of JPWO2022037528A5 publication Critical patent/JPWO2022037528A5/ja
Publication of JP2023539453A5 publication Critical patent/JP2023539453A5/ja
Application granted granted Critical
Publication of JP7821161B2 publication Critical patent/JP7821161B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023510435A 2020-08-20 2021-08-16 Bcmaと結合する単一可変ドメイン及び抗原結合分子 Active JP7821161B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010842501.X 2020-08-20
CN202010842501 2020-08-20
PCT/CN2021/112758 WO2022037528A1 (zh) 2020-08-20 2021-08-16 结合bcma的单可变结构域及抗原结合分子

Publications (4)

Publication Number Publication Date
JP2023539453A JP2023539453A (ja) 2023-09-14
JPWO2022037528A5 true JPWO2022037528A5 (https=) 2024-08-26
JP2023539453A5 JP2023539453A5 (https=) 2024-08-26
JP7821161B2 JP7821161B2 (ja) 2026-02-26

Family

ID=80323414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023510435A Active JP7821161B2 (ja) 2020-08-20 2021-08-16 Bcmaと結合する単一可変ドメイン及び抗原結合分子

Country Status (6)

Country Link
US (1) US20230265181A1 (https=)
EP (1) EP4201960A4 (https=)
JP (1) JP7821161B2 (https=)
KR (1) KR20230045095A (https=)
CN (1) CN115698077A (https=)
WO (1) WO2022037528A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117062840A (zh) * 2021-04-15 2023-11-14 正大天晴药业集团股份有限公司 靶向bcma的多特异性抗体
WO2025098446A1 (zh) * 2023-11-07 2025-05-15 赛斯尔擎生物技术(上海)有限公司 抗bcma单域抗体及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2406284B9 (en) * 2009-03-10 2017-03-01 Biogen MA Inc. Anti-bcma antibodies
UA112434C2 (uk) * 2011-05-27 2016-09-12 Ґлаксо Ґруп Лімітед Антигензв'язувальний білок, який специфічно зв'язується з всма
EP4282877A3 (en) 2016-08-10 2024-02-21 Legend Biotech Ireland Limited Chimeric antigen receptors targeting bcma and methods of use thereof
IL271194B2 (en) * 2017-06-20 2024-10-01 Teneobio Inc Anti-bcma heavy chain-only antibodies
AU2019214183B2 (en) * 2018-02-01 2022-04-07 Innovent Biologics (Suzhou) Co., Ltd. Fully human anti-B cell maturation antigen (BCMA) single chain variable fragment, and application thereof
CN109942708B (zh) 2019-03-28 2021-01-05 上海科棋药业科技有限公司 一种抗bcma的单域抗体及其应用
CN109942709B (zh) 2019-04-22 2019-12-27 广州百暨基因科技有限公司 一种抗bcma的单域抗体及其应用
CN117062840A (zh) * 2021-04-15 2023-11-14 正大天晴药业集团股份有限公司 靶向bcma的多特异性抗体

Similar Documents

Publication Publication Date Title
JP2020501531A5 (https=)
CN105968206B (zh) 抗erbb3抗体
JP2019536430A5 (https=)
JP2020525032A5 (https=)
JP2024062992A5 (https=)
JP2020520665A5 (https=)
JP2016505556A5 (https=)
CN111201238B (zh) 产生多特异性抗体混合物及其使用方法
JP2012526558A5 (https=)
JP2020516309A5 (https=)
HRP20120701T1 (hr) Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1
CN116396386A (zh) Cd3抗体及其药物用途
JP2011509245A5 (https=)
WO2015146437A1 (ja) 高機能性IgG2型二重特異性抗体
JP2021522303A5 (https=)
CN118076387A (zh) 靶向表达cdh17的肿瘤的多特异性抗体及其制备和使用方法
JPWO2020059847A5 (https=)
JP2014526902A (ja) イヌ化腫瘍壊死因子抗体及びその使用方法
JPWO2020159368A5 (https=)
JP2013519690A5 (https=)
JP2020531003A5 (https=)
CN115698077A (zh) 结合bcma的单可变结构域及抗原结合分子
JPWO2021222578A5 (https=)
JPWO2022111425A5 (https=)
CN111542537A (zh) 抗cd123抗体及其制备方法和应用